China Universal Asset Management Co., Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,766 shares of REGN stock, worth $11.2 Million. This represents 1.74% of its overall portfolio holdings.
Number of Shares
14,766
Previous 9,550
54.62%
Holding current value
$11.2 Million
Previous $10 Million
54.65%
% of portfolio
1.74%
Previous 1.43%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,529Shares Held
84.1MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.05 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.39 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.67 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.71 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.25 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $81.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...